GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » EV-to-EBITDA

Notable Labs (Notable Labs) EV-to-EBITDA : (As of May. 12, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Notable Labs EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Notable Labs's enterprise value is $1.50 Mil. Notable Labs does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Dec. 2023. Therefore, GuruFocus does not calculate Notable Labs's EV-to-EBITDA at this moment.

The historical rank and industry rank for Notable Labs's EV-to-EBITDA or its related term are showing as below:

NTBL' s EV-to-EBITDA Range Over the Past 10 Years
Min: -2.81   Med: 0.33   Max: 0.46
Current: -0.1

During the past 3 years, the highest EV-to-EBITDA of Notable Labs was 0.46. The lowest was -2.81. And the median was 0.33.

NTBL's EV-to-EBITDA is ranked worse than
100% of 462 companies
in the Biotechnology industry
Industry Median: 9.49 vs NTBL: -0.10

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-12), Notable Labs's stock price is $1.25. Notable Labs does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023. Therefore, GuruFocus does not calculate Notable Labs's PE Ratio at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Notable Labs EV-to-EBITDA Historical Data

The historical data trend for Notable Labs's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Notable Labs EV-to-EBITDA Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
EV-to-EBITDA
- - -0.50

Notable Labs Semi-Annual Data
Dec21 Dec22 Dec23
EV-to-EBITDA - - -0.50

Competitive Comparison of Notable Labs's EV-to-EBITDA

For the Biotechnology subindustry, Notable Labs's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Notable Labs's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Notable Labs's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Notable Labs's EV-to-EBITDA falls into.


Notable Labs EV-to-EBITDA Calculation

Notable Labs's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1.497/
=

Notable Labs  (NAS:NTBL) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Notable Labs's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.25/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Notable Labs EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Notable Labs's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Notable Labs (Notable Labs) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » EV-to-EBITDA
Comparable Companies
NLSP ACST AGE CRBP NBIO CLRB AIM PLUR BIXT SNSE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
320 Hatch Drive, Foster City, CA, USA, 94404
Website
https://notablelabs.com
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic.